Clinicopathological features and prognostic significance of HER2-low status in breast carcinoma

被引：0
|
作者：
Ilieva-Shipchanova, N. [1 ]
Tashkova, D. [1 ]
Bangieva, E. [1 ]
Miteva, N. [1 ]
机构：
[1] Med Univ Plovdiv, Complex Oncol Ctr Plovdiv, Plovdiv, Bulgaria
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-03
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [31] Comparison of Clinicopathological Features and Survival Outcomes Associated with HER2-Zero and HER2-Low Breast Cancers: A retrospective, Observational Study
    Ucar, Mahmut
    Yilmaz, Mukaddes
    Erdis, Eda
    Yucel, Birsen
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (04): : 220 - 230
  • [32] Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer
    Almstedt, Katrin
    Heimes, Anne-Sophie
    Kappenberg, Franziska
    Battista, Marco J.
    Lehr, Hans-Anton
    Krajnak, Slavomir
    Lebrecht, Antje
    Gehrmann, Mathias
    Stewen, Kathrin
    Brenner, Walburgis
    Weikel, Wolfgang
    Rahnenfuehrer, Joerg
    Hengstler, Jan G.
    Hasenburg, Annette
    Schmidt, Marcus
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 10 - 19
  • [33] Prognostic impact of HER2-low expression in HER2-negative breast cancer under different hormone receptor status
    Xu, Bin
    Shen, Jianguo
    Shen, Jun
    Wang, Linbo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (04) : 543 - 549
  • [34] STUDY OF EXPRESSION OF HER2/NEU IN CARCINOMA BREAST WITH REFERENCE TO CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC INDEX
    Josephin, Jeena J. R.
    Babu, Suresh K.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (90): : 6726 - 6732
  • [35] HER2-low versus HER2-0 in Invasive Lobular Breast Carcinoma
    Fontes-Sousa, M.
    de Sousa, L.
    Ribeiro, L.
    Torres, S. Pinto
    Costa, D. Alpuim
    Pinto, C. Gama
    Mestre, L.
    Borralho, P.
    Raimundo, A.
    Negreiros, I.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S86 - S87
  • [36] Prognostic impact of HER2-low expression in HER2-negative breast cancer under different hormone receptor status
    Bin Xu
    Jianguo Shen
    Jun Shen
    Linbo Wang
    International Journal of Clinical Oncology, 2023, 28 : 543 - 549
  • [37] Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
    Park, Ji Soo
    Rha, Sun Young
    Chung, Hyun Cheol
    Jung, Minkyu
    Kim, Ki Hyang
    Jun, Hyun Jung
    Kim, Hyunki
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    ONCOLOGY, 2015, 88 (03) : 147 - 156
  • [38] Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
    Zattarin, Emma
    Presti, Daniele
    Mariani, Luigi
    Sposetti, Caterina
    Leporati, Rita
    Menichetti, Alice
    Corti, Chiara
    Benvenuti, Chiara
    Fuca, Giovanni
    Lobefaro, Riccardo
    Ligorio, Francesca
    Provenzano, Leonardo
    Vingiani, Andrea
    Del Vecchio, Marta
    Griguolo, Gaia
    Sirico, Marianna
    Bernocchi, Ottavia
    Marra, Antonio
    Zagami, Paola
    Agostinetto, Elisa
    Jacobs, Flavia
    Di Mauro, Pierluigi
    Esposito, Andrea
    Giorgi, Carlo Alberto
    Lalli, Luca
    Boldrini, Laura
    Giacchetti, Pier Paolo Berton
    Schianca, Ambra Carnevale
    Guarneri, Valentina
    Pedersini, Rebecca
    Losurdo, Agnese
    Zambelli, Alberto
    Generali, Daniele
    Criscitiello, Carmen
    Curigliano, Giuseppe
    Pruneri, Giancarlo
    de Braud, Filippo
    Dieci, Maria Vittoria
    Vernieri, Claudio
    NPJ BREAST CANCER, 2023, 9 (01)
  • [39] Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
    Emma Zattarin
    Daniele Presti
    Luigi Mariani
    Caterina Sposetti
    Rita Leporati
    Alice Menichetti
    Chiara Corti
    Chiara Benvenuti
    Giovanni Fucà
    Riccardo Lobefaro
    Francesca Ligorio
    Leonardo Provenzano
    Andrea Vingiani
    Marta Del Vecchio
    Gaia Griguolo
    Marianna Sirico
    Ottavia Bernocchi
    Antonio Marra
    Paola Zagami
    Elisa Agostinetto
    Flavia Jacobs
    Pierluigi Di Mauro
    Andrea Esposito
    Carlo Alberto Giorgi
    Luca Lalli
    Laura Boldrini
    Pier Paolo Berton Giacchetti
    Ambra Carnevale Schianca
    Valentina Guarneri
    Rebecca Pedersini
    Agnese Losurdo
    Alberto Zambelli
    Daniele Generali
    Carmen Criscitiello
    Giuseppe Curigliano
    Giancarlo Pruneri
    Filippo de Braud
    Maria Vittoria Dieci
    Claudio Vernieri
    npj Breast Cancer, 9
  • [40] Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer
    Yue, Meng
    Wu, Si
    Liu, Chang
    Cai, Lijing
    Wang, Xinran
    Jia, Ying
    Han, Dandan
    Liu, Yueping
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 373 - 381
12345